Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Advances in systemic sclerosis and related fibrotic and vascular conditions

Email this article to a friend

Clinical trials in systemic sclerosis: lessons learned and outcomes

Marco Matucci-Cerinic*, Virginia D Steen, Daniel E Furst and James R Seibold

Arthritis Research & Therapy 2007, 9(Suppl 2):S7 doi:10.1186/ar2191

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.